Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Journal of Cardiac Failure
|
April 29, 2009
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)
Jalal K Ghali, John Wikstrand, Dirk J Van Veldhuisen, et al.
JACC. Heart Failure
|
March 14, 2014
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure)
Ana Cristina Perez, Pardeep S Jhund, David J Stott, et al.
European Journal of Heart Failure
|
March 15, 2013
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials
Thor Ueland, Ståle H Nymo, Roberto Latini, et al.
European Journal of Heart Failure
|
May 27, 2010
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)
Sally C Inglis, John J V McMurray, Michael Böhm, et al.
JAMA Cardiology
|
December 16, 2020
Assessing the Role of Rare Genetic Variation in Patients With Heart Failure
Gundula Povysil, Olympe Chazara, Keren J Carss, et al.
BMC Medical Genetics
|
December 22, 2014
The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
Vincent G Haver, Niek Verweij, John Kjekshus, et al.
European Journal of Heart Failure
|
January 27, 2009
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide
Hans Wedel, John J V McMurray, Magnus Lindberg, et al.
European Journal of Heart Failure
|
December 22, 2009
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial
Paula K Lorgelly, Andrew H Briggs, Hans Wedel, et al.
JACC. Heart Failure
|
June 23, 2014
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)
Jennifer K Rogers, Pardeep S Jhund, Ana-Cristina Perez, et al.
Journal of the American College of Cardiology
|
October 2, 2010
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure)
John J V McMurray, Peter Dunselman, Hans Wedel, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Journal of Cardiac Failure
|
April 29, 2009
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)
Jalal K Ghali, John Wikstrand, Dirk J Van Veldhuisen, et al.
JACC. Heart Failure
|
March 14, 2014
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure)
Ana Cristina Perez, Pardeep S Jhund, David J Stott, et al.
European Journal of Heart Failure
|
March 15, 2013
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials
Thor Ueland, Ståle H Nymo, Roberto Latini, et al.
European Journal of Heart Failure
|
May 27, 2010
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)
Sally C Inglis, John J V McMurray, Michael Böhm, et al.
JAMA Cardiology
|
December 16, 2020
Assessing the Role of Rare Genetic Variation in Patients With Heart Failure
Gundula Povysil, Olympe Chazara, Keren J Carss, et al.
BMC Medical Genetics
|
December 22, 2014
The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
Vincent G Haver, Niek Verweij, John Kjekshus, et al.
European Journal of Heart Failure
|
January 27, 2009
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide
Hans Wedel, John J V McMurray, Magnus Lindberg, et al.
European Journal of Heart Failure
|
December 22, 2009
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial
Paula K Lorgelly, Andrew H Briggs, Hans Wedel, et al.
JACC. Heart Failure
|
June 23, 2014
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)
Jennifer K Rogers, Pardeep S Jhund, Ana-Cristina Perez, et al.
Journal of the American College of Cardiology
|
October 2, 2010
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure)
John J V McMurray, Peter Dunselman, Hans Wedel, et al.
Page
of 12